TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells

E Costantino, F Maddalena, S Calise, A Piscazzi… - Cancer letters, 2009 - Elsevier
TRAP1 is a component of a pro-survival mitochondrial pathway up-regulated in tumor cells.
The evaluation of TRAP1 expression in 26 human colorectal carcinomas showed up …

[HTML][HTML] Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1

F Maddalena, L Sisinni, G Lettini, V Condelli… - Molecular …, 2013 - Elsevier
TRAP1 is a mitochondrial antiapoptotic protein up-regulated in several human
malignancies. However, recent evidences suggest that TRAP1 is also localized in the …

NRF2 knockdown resensitizes 5-fluorouracil-resistant pancreatic cancer cells by suppressing HO-1 and ABCG2 expression

EJ Kim, YJ Kim, HI Lee, SH Jeong, HJ Nam… - International journal of …, 2020 - mdpi.com
Chemoresistance is a leading cause of morbidity and mortality in patients with pancreatic
cancer and remains an obstacle to successful treatment. The antioxidant transcription factor …

Sorcin Induces a Drug-Resistant Phenotype in Human Colorectal Cancer by Modulating Ca2+ Homeostasis

F Maddalena, G Laudiero, A Piscazzi, A Secondo… - Cancer research, 2011 - AACR
The Ca2+-binding protein sorcin regulates intracellular calcium homeostasis and plays a
role in the induction of drug resistance in human cancers. Recently, an 18 kDa mitochondrial …

[HTML][HTML] LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis

H Du, S Hou, L Zhang, C Liu, T Yu, W Zhang - Aging (Albany NY), 2023 - ncbi.nlm.nih.gov
Background: LncRNA is an important regulatory factor in the human genome. We aim to
explore the roles of LncFALEC and miR-20a-5p/SHOC2 axis on the proliferation, migration …

IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells

T Notarangelo, L Sisinni, S Trino, G Calice, V Simeon… - Cancer Letters, 2018 - Elsevier
Thyroid carcinomas (TCs) bearing BRAF mutations represent approximately 26–53% of
human thyroid malignancies and, differently from melanomas, are poorly sensitive to BRAF …

Treatment of colorectal cancer using a combination of liposomal irinotecan (Irinophore C™) and 5-fluorouracil

JI Hare, RW Neijzen, M Anantha, N Dos Santos… - PloS one, 2013 - journals.plos.org
Purpose To investigate the use of liposomal irinotecan (Irinophore C™) plus or minus 5-
fluorouracil (5-FU) for the treatment of colorectal cancer. Experimental Design The effect of …

[HTML][HTML] TRAP1 role in endoplasmic reticulum stress protection favors resistance to anthracyclins in breast carcinoma cells

L Sisinni, F Maddalena, G Lettini… - International …, 2014 - spandidos-publications.com
Adaptation to endoplasmic reticulum (ER) stress through the upregulation of the ER
chaperone BiP/Grp78 favors resistance of cancer cells to anthracyclins. We recently …

Optimized anti–tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule

H Ehrhardt, D Schrembs, C Moritz… - Blood, The Journal …, 2011 - ashpublications.org
Application of anthracyclines and Vinca alkaloids on the same day represents a hallmark of
polychemotherapy protocols for hematopoietic malignancies. Here we show, for the first …

Enhanced anti‐tumour effects of V inca alkaloids given separately from cytostatic therapies

H Ehrhardt, L Pannert, S Pfeiffer… - British journal of …, 2013 - Wiley Online Library
Background and Purpose In polychemotherapy protocols, that is for treatment of
neuroblastoma and E wing sarcoma, Vinca alkaloids and cell cycle‐arresting drugs are …